Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
about
Histological and molecular evaluation of patient-derived colorectal cancer explantsCancer Stem Cells in Human Gastrointestinal CancerMesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer ProgressionCancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor GrowthDirect Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer InvasionClinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathwayOverview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidThe Role of Stroma in Tumor DevelopmentThe microenvironment in breast cancer progression: biology and implications for treatmentApproaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cellsTumor endothelial cellsRole of oxidative stress and the microenvironment in breast cancer development and progressionRationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategyMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesCancer-associated fibroblasts in digestive tumorsStromal characteristics may hold the key to mammographic density: the evidence to dateThe application of the fibroblast activation protein α-targeted immunotherapy strategyMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentCarcinoma-associated fibroblasts: orchestrating the composition of malignancyHematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironmentExploring the tumor microenvironment with nanoparticlesFibroblast activation protein α in tumor microenvironment: recent progression and implications (review)Functional investigation of NCI-H460-inducible myofibroblasts on the chemoresistance to VP-16 with a microfluidic 3D co-culture deviceA vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingThe extracellular matrix: a dynamic niche in cancer progressionTheranostic Probes for Targeting Tumor Microenvironment: An Overview.Tumors as organs: complex tissues that interface with the entire organismCancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer modelTargeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.Stroma in breast development and disease.Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicityCo-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.Stromal regulation of vessel stability by MMP14 and TGFbeta.Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cellsCancer targeted therapeutics: From molecules to drug delivery vehicles.Dissecting the role of bone marrow stromal cells on bone metastases.Fibroblast heterogeneity in the cancer wound.Cancer associated fibroblasts (CAFs) in tumor microenvironment.Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model
P2860
Q21134541-30448ED4-02D1-421F-8DE8-19D5F8E0F44DQ26737714-C7B4B880-B688-45E5-9472-753E36826537Q26770002-3659D54B-6315-4080-B725-949C8A55EC85Q26774159-96953725-B05E-49AC-BCE6-CF4A816E7E6AQ26782289-07D7401C-C8A7-4C65-A07B-E6F393E75118Q26797238-D91350EE-10C9-4316-9FF5-08FE0F8EDE5AQ26799981-D49CC09F-3184-476B-8B50-65C577D5239CQ26801843-0456CED2-429C-4001-9A9D-6ED4BEA5D2CAQ26851314-C0941F65-CA01-45CA-94B7-CDB47CCACC7FQ26852287-CB083FA7-A104-4D93-9EDD-378F0E02C7F2Q26995733-54226435-298B-4E0B-A6CB-75BE51051B5FQ27003859-E59E1DCB-51F4-43C4-9059-71113285ECAEQ27004215-A1791AEF-C7B5-4619-812E-E665F9C624E3Q27011598-73D157DF-BEED-42CD-B7F2-A202B466BF38Q27022816-1C5D8AAE-6D7F-4FD0-B72B-DDDCA63DD367Q28066162-7FDA155F-F22B-4DA4-85C3-845A4D70C701Q28073437-F5C7F699-2FAF-435F-B7DB-A29660B5661FQ28073613-FDC645C2-0342-4111-AE28-0CFE8149EB3BQ28078667-F559A2D2-3187-4D08-AEE8-A8456B324C42Q28080529-2FFA1518-1564-44CA-BC07-04D9F9BB1630Q28082374-10E287B7-C39D-4F6D-B4EA-09D7ACBC612FQ28082504-B697C8BD-5B39-45CD-82AD-A8725399B381Q28486232-9B892A92-450F-43CE-B2F3-3FCF6E3411B6Q28537598-20F93275-38D2-4127-AFF2-E8D05825A243Q29617793-E705E463-1E89-4142-9875-4DC293B0B07AQ30354655-3C907D80-0FB2-4062-A701-64B45CA7AB7EQ30495528-48857AE4-E912-47A6-9F6D-EE28A0056CEEQ33517133-B2B3F536-A18D-4BF8-B903-D39EC9FC07EEQ33555573-852A36E8-83EA-4C28-826B-BB168C402B82Q33663923-C42CA6B4-8328-4B08-9869-72240F83303FQ33698636-A7B58172-564E-4C00-8C0B-1219B7866753Q33716011-24B127E2-F306-4E43-9C97-AB82AAD8C3A7Q33719861-813EC3FB-0A1F-4B8A-B082-67C6BD92A07BQ33815414-0B67E8FE-4DAE-44F4-8864-71F1E41F33ACQ33875288-76107ED3-10C4-4213-A5BC-032F84BE1D25Q33887986-75F0192F-4E51-45C9-BB13-E591675EDC66Q33904588-FD9FAAAA-5E0E-4D2D-8011-C0218BEAA42FQ33964324-6451A8C6-6C12-4536-BB44-589F4D6D56D5Q33999773-DEA2D8CE-21D1-46C6-A415-9B552331AF69Q34049485-4E522FB1-607C-4293-8089-4EFD4FFF3054
P2860
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@ast
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@en
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@nl
type
label
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@ast
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@en
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@nl
prefLabel
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@ast
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@en
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@nl
P2093
P2860
P356
P1476
Targeting tumor-associated fib ...... asing intratumoral drug uptake
@en
P2093
Andreas G Niethammer
Jörg A Krüger
Markus Loeffler
Ralph A Reisfeld
P2860
P304
P356
10.1172/JCI26532
P407
P577
2006-06-22T00:00:00Z